Key result
Viruses competitively bind importin alpha to block transcription factor transport and suppress antiviral genes.
Why the study?
Viruses develop mechanisms to evade host innate immune responses by blocking importin alpha-mediated nuclear transport of key antiviral transcription factors.
This review highlights how various viruses evade host innate immunity by competitively inhibiting importin alpha-mediated nuclear import of antiviral transcription factors.
Viral importin alpha targeting may reveal broad antiviral strategies; leaves open clinical translation pending targeted validation.
Cellular nucleocytoplasmic trafficking is mediated by the importin family of nuclear transport proteins. The well-characterized importin alpha (IMPA) and importin beta (IMPB) nuclear import pathway plays a crucial role in the innate immune response to viral infection by mediating the nuclear import of transcription factors such as IRF3, NFκB, and STAT1. The nuclear transport of these transcription factors ultimately leads to the upregulation of a wide range of antiviral genes, including IFN and IFN-stimulated genes (ISGs). To replicate efficiently in cells, viruses have developed mechanisms to block these signaling pathways. One strategy to evade host innate immune responses involves blocking the nuclear import of host antiviral transcription factors. By binding IMPA proteins, these viral proteins prevent the nuclear transport of key transcription factors and suppress the induction of antiviral gene expression. In this review, we describe examples of proteins encoded by viruses from several different families that utilize such a competitive inhibition strategy to suppress the induction of antiviral gene expression.
No takes yet. Share an insight, caveat, or question.
Vogel et al. (2023) conducted a review in Viral infection. Viral proteins binding IMPA proteins was evaluated on Suppression of antiviral gene expression. Viruses from several families utilize a competitive inhibition strategy by binding importin alpha proteins to prevent the nuclear transport of key transcription factors and suppress antiviral genes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: